Janas-Boratyńska M, Szewczyk Z
Arch Immunol Ther Exp (Warsz). 1979;27(6):833-45.
The effect of immunosuppressive and anti-inflammatory drugs on the T and B lymphocyte populations, as well as cellular hypersensitivity in relation to GBM antigens (measured by MIF activity) in 60 patients with different types of glomerulopathy has been tested. The results were compared with a control group of 47 untreated patients and 32 healthy subjects. The treatment was carried out using the following drugs: azathioprine, cyclophosphamide, prednisone, ibuprofen and indomethacin. In a sample of 14 patients receiving ibuprofen and in 7 receiving arathioprine, indomethacin and prednisone, the T and B lymphocyte kinetics as well as MIF activity were repeatedly tested before and during the treatment of 150 days. In the patients under this treatment, a decreased percentage of lymphocytes with receptors for a complement as well as, in some cases. MIF suppression was observed. A comparison of healthy subjects and untreated patients with a group of 39 subjects tested for T and B lymphocytes as well as MIF activity after several months of the above treatment was made. It was found that supportive therapy with azathioprine and prednisone led to a normalization of B lymphocytes (EA and EAC rosettes) and to a small increase of T lymphocytes number. On the other hand, treatment with indomethacin and ibuprofen led to an increased B lymphocyte count (EA and EAC rosettes). Cyclophosphamide given with azathioprine caused a decrease in the proportion of T lymphocytes and an increase in the number of null cells. In addition, it was found that immunosuppressive drugs as well as anti-inflammatory drugs, even when administered in supportive doses caused in some cases, the suppression of cellular immunity as measured by MIF activity.
已对60例不同类型肾小球病患者使用免疫抑制和抗炎药物后T和B淋巴细胞群体的影响,以及与胶质母细胞瘤抗原相关的细胞超敏反应(通过巨噬细胞移动抑制因子活性测定)进行了测试。将结果与47例未经治疗的患者和32例健康受试者组成的对照组进行比较。使用以下药物进行治疗:硫唑嘌呤、环磷酰胺、泼尼松、布洛芬和吲哚美辛。在14例接受布洛芬治疗的患者以及7例接受硫唑嘌呤、吲哚美辛和泼尼松治疗的患者样本中,在150天治疗前和治疗期间反复测试了T和B淋巴细胞动力学以及巨噬细胞移动抑制因子活性。在接受这种治疗的患者中,观察到具有补体受体的淋巴细胞百分比降低,在某些情况下还观察到巨噬细胞移动抑制因子受到抑制。将健康受试者和未经治疗的患者与一组39名受试者进行比较,这组受试者在上述治疗几个月后进行了T和B淋巴细胞以及巨噬细胞移动抑制因子活性测试。发现硫唑嘌呤和泼尼松的支持性治疗导致B淋巴细胞(EA和EAC玫瑰花结)正常化,T淋巴细胞数量略有增加。另一方面,吲哚美辛和布洛芬治疗导致B淋巴细胞计数增加(EA和EAC玫瑰花结)。与硫唑嘌呤联合使用环磷酰胺导致T淋巴细胞比例降低,裸细胞数量增加。此外,还发现免疫抑制药物以及抗炎药物,即使以支持剂量给药,在某些情况下也会导致通过巨噬细胞移动抑制因子活性测量的细胞免疫受到抑制。